ReviewCancers2026

The Central Role of HLA Class II-Restricted Helper Neoantigen Vaccines in Cancer Immunotherapy.

Takafumi Morisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.